CIC-REARRANGED SARCOMA
Clinical trials for CIC-REARRANGED SARCOMA explained in plain language.
Never miss a new study
Get alerted when new CIC-REARRANGED SARCOMA trials appear
Sign up with your email to follow new studies for CIC-REARRANGED SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BTX-A51 tested in rare sarcomas
Disease control OngoingThis early study tests an oral drug called BTX-A51 in 24 people with advanced liposarcoma (a type of fat tissue cancer) that has spread or come back. The main goal is to see if the drug is safe and tolerable at different doses. It focuses on specific genetic subtypes: MDM2-amplif…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New cocktail of cancer drugs shows promise for Tough-to-Treat sarcoma
Disease control OngoingThis study tests whether adding three drugs (vincristine, irinotecan, and regorafenib) to standard chemotherapy can help people with Ewing sarcoma that has spread. About 437 participants will receive either the new combo or standard treatment. The goal is to see if the new approa…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Cancer drug regorafenib tested to halt bone sarcoma spread
Disease control OngoingThis phase 2 trial tests whether the drug regorafenib can stop or slow the growth of metastatic bone sarcomas (cancers that started in bone and spread). 163 patients with osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma are randomly assigned to receive regorafenib or a pl…
Matched conditions: CIC-REARRANGED SARCOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC